期刊文献+

p16和cyclin D2在卵巢颗粒细胞瘤中的表达及临床意义 被引量:1

Expression and the clinical significance of p16 and cyclin D2 in human ovarian cell tumor
下载PDF
导出
摘要 目的研究p16和细胞周期蛋白D2(cyclin D2)在人卵巢颗粒细胞瘤中的表达及临床意义。方法实验组选取80例经病理医师诊断为卵巢颗粒细胞瘤的石蜡切片,用免疫组织化学法检测其中的p16和cyclin D2表达的变化,并与健康对照组比较。结果p16和cyclin D2在卵巢颗粒细胞瘤组的表达率分别为12.50%和81.25%,在对照组的表达率分别为27.78%和38.89%,两组间比较差异有统计学意义(P<0.05)。p16与cyclin D2在卵巢颗粒细胞瘤中的表达呈负相关关系。结论人卵巢颗粒细胞瘤中cyclin D2表达明显增高,而p16的表达明显降低,对研究卵巢颗粒细胞瘤的发病,发生具有重要意义。 Objective To investigate the expression of p16,cyclin D2 in human ovarion granulose cell tumor and the clinical significance. Methods The paraffin sections from 80 patients diagnosed as ovation granulose cell tumor were collected. Experssion of p16 and eyclin D2 was measured with immunohistochemistry. Results The expression rates of p16 and cyclin D2 in ovarian granulosa cell tumor were 12.50%and 81. 25% respectively,while the rates were 27.78%and 38.89% respetively in normal ovarian tissues and there was a significant difference between the two groups(P〈0.05). The expression of p16 was correlated with that of cyclin D2 with the correlation coeffi cient being -0. 45. Conclusion The results of p16 and cyclin D2 could be used as the study of the occurence of ovarian granulosa cell tumor.
出处 《检验医学与临床》 CAS 2010年第7期607-608,610,共3页 Laboratory Medicine and Clinic
关键词 卵巢颗粒细胞瘤 P16 CYCLIN D2 免疫组织化学 ovarian granulosa cell tumor p16 cyclin D2 immunohistochemistry
  • 相关文献

参考文献6

  • 1卫莹,周颖,凌斌.卵巢颗粒细胞瘤的分子机制研究进展[J].山东医药,2009,49(13):113-115. 被引量:5
  • 2King LA,Okagaki T,Gallup DG,et al.Mitoticcount,nuclearatypia,andimmunohistochemical determination of Ki267,C2myc,p21 ras,C2erbB2 and p53 expression in granulosa cell tumors of the ovary:mitotic count and Ki267 are indicators of poor prognosis[J].Gyneco Oncol,1996,61(2):227-230.
  • 3Gansauge S,Gansauge F,Ramadani M,et al.Overexpression of cyclinD1 in human pancreatic carcinoma is associated wit h poorprognosis[J].Cancer Res,1997,57(6):1634-1637.
  • 4Serrano M,Hannon GJ,Beach D.A new regulato rymo tif in cell cycle contro l causing specific inh ibition of cyclin D? CDK4[J].Nature,1993,366:704-707.
  • 5Garber K.Beyond the Nabel Price:cell cycle and apoptasis[J].J Natl Cancer Inst,2001,93:1766-1768.
  • 6Evan G1,Vousden KH.Proliferation,cell cycle and apoptasis in cancer[J].Natuer,2001,411:342-345.

二级参考文献8

  • 1Dhillon VS, Aslam M, Husain SA. The contribution of genetic and epigenetic changes in granulosa cell tumors of ovarian origin [ J ]. Clin Cancer Res, 2004,10(16) :5537-5545.
  • 2Bcerboom D, Paquet M, Hsieh M, et al. Misregnlated Wnt/betacetenin signaling leads to ovarian granulosa cell tumor development [ J]. Cancer Res, 2005,65 (20) :9206-9215.
  • 3Peter J, Fuller SC. Signalling pathways in the molecular pathogenesis of ovarian granulosa cell tumours [ J ]. Trends Endocrinol Metabol, 2004,15(3) :122-128.
  • 4Arcellana-Panlilio MY, Egeler RM, Ujaek E, et al. Evidence of a role for the INK4 family of eyelin-dependent kinase inhibitors in ovarian granulosa cell tumors [ J ]. Genes Chromosomes Cancer, 2002,35(2) : 176-181.
  • 5McCluggage WG, McKenna M, McBride HA. CD56 is a sensitive and diagnostically useful immunohistochemical marker of ovarian sex cord-stromal tumors [ J ], Int J Gynecol Pathol, 2007,26 ( 3 ) : 322- 327.
  • 6Kalfa N, Philibert P, Patte C, et al. Extinction of FOXL2 expression in aggressive ovarian granulosa cell tumors in children[J]. Fertil Steril, 2007,87(4) :896-901.
  • 7Chu S, Alexiadis M, Fuller PJ. Expression, mutational analysis and in vitro response of imatinib mesylate and nilotinib target genes in ovarian granulosa cell tumors[J]. Gynecol Oncol, 2008,108 ( 1 ) :182-190.
  • 8Fuller PJ, Zumpe ET, Chu S, et al. Inhibin-aetivin receptor subunit gene expression in ovarian tumors [ J ]. J Clin Endocrinol Metab, 2002,87(3) :1395-1401.

共引文献4

同被引文献7

  • 1Lu Q, Kaplan M, Ray D, et al. Demethylation of ITGAL (CDlla) regulatory sequences in systemic lupus erythema- tosus[J]. Arthritis Rheum,2002,46(5) : 1282-1291.
  • 2OelkeK, Lu Q, Richardson D, et al. Overexpression of CDT0 and overstimulation of IgG synthesis by luPus Tcells and T cells treated with DNA methylation inhibitors [J]. Arthritis Rheum, 2004,50(6) : 1850-1860.
  • 3Kaplan M, Lu Q,Wu A, et al. Demethylation of promoter regulatory elements contributes to perform overexpression in CD4+ lupus T cells[J]. J Immunol, 2004,172(6):3652 3661.
  • 4Katsiari CG, Liossis SN, DimoPoulos AM, et al. CI)40L overexpression on T cells and monocyles from patients with systmie lupus erythematosus is resistant to calcineurin inhibition[J]. Lupus,2002,11(6) :370 378.
  • 5李海平,张吉才,范金波,吕军,冯景,余宗涛.乙型病毒性肝炎和肝硬化患者外周血中p16启动子异常甲基化分析[J].中华检验医学杂志,2008,31(2):182-183. 被引量:3
  • 6陆前进,卢放根,颜兰香,文海泉,张其亮,张桂英,余桂英,杨竹林.银屑病患者皮损中CDK_4和p16蛋白表达[J].中华皮肤科杂志,1998,31(2):104-105. 被引量:10
  • 7张杰.银屑病患者CDKN2A甲基化状态研究[J].中华实用诊断与治疗杂志,2012,26(2):130-131. 被引量:8

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部